by Stephanie Wood Miller | Jul 8, 2024 | Weekly Cannabis News, Weekly News
This week the Federal government addresses key issues related to testing and clinical research in cannabis. States see impressive revenues from legalization. The NCAA removes marijuana from its banned substances list. States generating big revenue from legalization...
by Stephanie Wood Miller | Jun 17, 2024 | Science, Weekly Cannabis News, Weekly News
The federal government solicits public comment on rescheduling marijuana until July 22, 2024. Take a look at people are saying or submit a comment. A round up of studies looking at the benefits of medicinal marijuana and some of the concerns. Comparing the damage of...
by Stephanie Wood Miller | Jun 10, 2024 | Weekly Cannabis News, Weekly News
A study out this week from the American Medical Association suggests that consumers use marijuana primarily for health issues. Two studies suggest that the old “stoner” stereotype may be inaccurate. An early phase test in mice suggests that terpenes may be more...
by Stephanie Wood Miller | May 20, 2024 | Weekly News
Today is all about reclassifying marijuana from a Schedule I to a Schedule III drug and the impact it may have or may not have in the U.S. We’ve included a perspective from the Washington D.C.’s The Hill, Kyle Jaeger at Marijuana Moment, the ACLU and our own scientist...
by Stephanie Wood Miller | Apr 30, 2024 | Science, Weekly Cannabis News, Weekly News
According to Associated Press this morning the FDA will move to reclassify marijuana from a Schedule I to a Schedule III drug. Schedule I drugs have a high potential for abuse and no accepted medical use, while Schedule III drugs have a lower potential for abuse and...
